Newsfeeds - Spark Newswire

5 minute read

66 Biggest Movers From Yesterday

August 18, 5:35 AM

Gainers Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) shares surged 265.5% to close at $15.35 on Tuesday after the company received a written pre-investigational new drug (pre-IND) response from the FDA regarding MMS019.

ABUS

20 minute read

Stocks That Hit 52-Week Lows On Tuesday

By Benzinga Insights

August 17, 10:12 AM

Tuesday morning, 282 companies set new 52-week lows.

AAOI

8 minute read

The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business

By Shanthi Rexaline

August 17, 8:28 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16)

ABSI

14 minute read

Stocks That Hit 52-Week Lows On Monday

By Benzinga Insights

August 16, 10:12 AM

On Monday morning, 207 companies hit new 52-week lows.

ACAD

5 minute read

Praxis Precision Medicines Reports PRAX-114 Perimenopausal Depression Phase 2a Proof-of-Concept Trial Results; Says ‘PRAX-114 showed rapid and marked improvements in menopausal and mood symptoms’

By Bill Haddad

August 16, 7:56 AM

PRAX-114 showed rapid and marked improvements in menopausal and mood symptoms in Phase 2a PMD study PRAX-114 was well tolerated in Phase 2a PMD study with no change in overall safety profile CAMBRIDGE, Mass.,

PRAX

6 minute read

The Daily Biotech Pulse: Moderna’s Vaccine Produces Durable Response Against Variants, FDA Approves Jazz’s Sleep Disorder Drug, Dermata IPO

By Shanthi Rexaline

August 13, 7:43 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 12)

ABVC

7 minute read

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight

By Shanthi Rexaline

August 8, 10:03 AM

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in, triggering stock-specific moves, while clinical readouts also moved stocks during the week.

ABCL